Researchers Julius-Maximilians-Universität (JMU; Würzburg, Germany), the University of Geneva (Geneva, Switzerland) and Monash University (Melbourne, Australia) have been able to create fluorescence imagining with molecular resolution to image cell structures, for the first time, by combining two previously incompatible microscopy methods.
SCIEX (MA, USA), a global leader in life science analytical technology, recently announced the launch of the next generation of their flagship nominal mass spectrometer, the SCIEX Triple Quad™ 7500 LC-MS/MS System – QTRAP® Ready.
Trajan Scientific and Medical (Melbourne, Australia) has listed its hemaPEN® blood microsampling device with the US FDA as Class I for therapeutic and in vitro diagnostic use.
A team from The University of Texas at Austin (TX, USA) are developing a sensor capable of testing for COVID-19 and influenza simultaneously.
Q2 Solutions (NC, USA) and LGC (Cambridge, UK) have announced a strategic global bioanalytical partnership between the two companies.
A simple sweat collection and analysis device from Penn State University (PA, USA) and Xiangtan University (Xiangtan, China) could assist healthcare professionals with diagnosising and monitoring disease progression by measuring biomarkers, such as pH and glucose.
Researchers have developed a thread-based bioluminescence sensor capable of detecting antibodies in a finger prick sample of whole blood.
FDA grants Breakthrough Device Designation to Thermo Fisher’s assay for identifying low-grade glioma patients eligible for vorasidenib.
BioAgilytix (NC, USA), a Durham-based CRO, have announced the launch of customizable testing packages to address the requirements of employees and sponsors as a result of the COVID-19 pandemic.
Avacta (Cambridge, UK) has announced that the bead-assisted mass spectrometry test for COVID-19, currently in development with Adeptrix (MA, USA), has reached prototype stage.